CIK 0001156039 · Large accelerated filer
Elevance Health, Inc.
Sign in to watch- Ticker
- ELV
- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- IN
- Entity type
- operating
- EIN
- 352145715
- Phone
- 8003311476
- Business address
- 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
- Former names
- Anthem, Inc., WELLPOINT, INC, WELLPOINT INC, ANTHEM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,230,357
- in 2 filings
Net −$5,230,357. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-18 | CLARK R KERRY Director | Grant or award | +440 | 8,194 | ||
| 2022-05-18 | Tallett Elizabeth E Director | Grant or award | +440 | 9,446 | ||
| 2022-05-18 | Schneider Ryan M. Director | Grant or award | +440 | 5,154 | ||
| 2022-05-18 | Jallal Bahija Director | Grant or award | +440 | 3,342 | ||
| 2022-05-18 | Dixon Robert L JR Director | Grant or award | +440 | 9,911 | ||
| 2022-03-10 | Haytaian Peter D EVP & Pres., DBG & IngenioRx | Option exercise | +1,848 | $131.80 | $244K | 29,864 |
| 2022-03-10 | Haytaian Peter D EVP & Pres., DBG & IngenioRx | Sale | −2,170 | $458.68 | $995K | 27,694 |
| 2022-03-10 | Haytaian Peter D EVP & Pres., DBG & IngenioRx | Sale | −4,274 | $459.75 | $2.0M | 23,420 |
| 2022-03-10 | Haytaian Peter D EVP & Pres., DBG & IngenioRx | Sale | −4,105 | $460.68 | $1.9M | 19,315 |
| 2022-03-10 | Haytaian Peter D EVP & Pres., DBG & IngenioRx | Sale | −5,874 | $461.72 | $2.7M | 13,441 |
| 2022-03-10 | Haytaian Peter D EVP & Pres., DBG & IngenioRx | Sale | −1,240 | $462.73 | $574K | 12,201 |
| 2022-03-10 | Haytaian Peter D EVP & Pres., DBG & IngenioRx | Sale | −40 | $463.40 | $19K | 12,161 |
| 2022-03-10 | Haytaian Peter D EVP & Pres., DBG & IngenioRx | Option exercise · Employee Stock Option (Right to Buy) | −1,848 | 0 | ||
| 2022-03-03 | Penczek Ronald W CAO & Controller | Option exercise | +438 | $311.48 | $136K | 3,204 |
| 2022-03-03 | Penczek Ronald W CAO & Controller | Option exercise | +653 | $271.27 | $177K | 3,857 |
| 2022-03-03 | Penczek Ronald W CAO & Controller | Option exercise | +468 | $307.68 | $144K | 4,325 |
| 2022-03-03 | Penczek Ronald W CAO & Controller | Sale | −2,423 | $463.68 | $1.1M | 1,902 |
| 2022-03-03 | Penczek Ronald W CAO & Controller | Option exercise · Employee Stock Option (Right to Buy) | −438 | 877 | ||
| 2022-03-03 | Penczek Ronald W CAO & Controller | Option exercise · Employee Stock Option (Right to Buy) | −653 | 654 | ||
| 2022-03-03 | Penczek Ronald W CAO & Controller | Option exercise · Employee Stock Option (Right to Buy) | −468 | 0 |
Page 16 of 26 · 514 trades